UK markets open in 7 minutes
NIKKEI 225
37,068.35 -1,011.35 (-2.66%) HANG SENG
16,218.90 -166.97 (-1.02%) CRUDE OIL
83.87 +1.14 (+1.38%) GOLD FUTURES
2,397.40 -0.60 (-0.03%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
51,566.89 +2,491.94 (+5.08%)
Theravance Biopharma, Inc. (TBPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 447.24M |
| Enterprise value | 393.97M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.87 |
| Price/book (mrq) | 2.10 |
| Enterprise value/revenue | 6.86 |
| Enterprise value/EBITDA | -9.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.35 |
| 52-week change 3 | -20.42% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 11.98 |
| 52-week low 3 | 8.21 |
| 50-day moving average 3 | 8.98 |
| 200-day moving average 3 | 9.64 |
Share statistics
| Avg vol (3-month) 3 | 367.12k |
| Avg vol (10-day) 3 | 461.07k |
| Shares outstanding 5 | 48.56M |
| Implied shares outstanding 6 | 48.56M |
| Float 8 | 15.86M |
| % held by insiders 1 | 14.51% |
| % held by institutions 1 | 103.37% |
| Shares short (28 Mar 2024) 4 | 7.52M |
| Short ratio (28 Mar 2024) 4 | 21.12 |
| Short % of float (28 Mar 2024) 4 | 30.45% |
| Short % of shares outstanding (28 Mar 2024) 4 | 15.49% |
| Shares short (prior month 29 Feb 2024) 4 | 8.61M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -96.11% |
| Operating margin (ttm) | -35.53% |
Management effectiveness
| Return on assets (ttm) | -6.73% |
| Return on equity (ttm) | -16.86% |
Income statement
| Revenue (ttm) | 57.42M |
| Revenue per share (ttm) | 1.04 |
| Quarterly revenue growth (yoy) | 19.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -53.19M |
| Net income avi to common (ttm) | -55.19M |
| Diluted EPS (ttm) | -1.00 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 102.43M |
| Total cash per share (mrq) | 2.13 |
| Total debt (mrq) | 49.16M |
| Total debt/equity (mrq) | 23.08% |
| Current ratio (mrq) | 5.39 |
| Book value per share (mrq) | 4.43 |
Cash flow statement
| Operating cash flow (ttm) | -27M |
| Levered free cash flow (ttm) | -13.89M |
© 2024 Yahoo. All rights reserved.